| 1 |
Craig M. Whitehouse |
Analytica Of Branford |
5 |
| 2 |
Christopher J. Criscuolo |
Covidien Lp |
4 |
| 3 |
Mario Sabatini |
— |
2 |
| 3 |
Nicholas Maiorino |
Covidien Lp |
2 |
| 3 |
Michael Jeffrey Brookman |
Averill Partners |
2 |
| 3 |
Kevin J. Chase |
R.T. Vanderbilt Company |
2 |
| 3 |
Mehdi Mesri |
Celera |
2 |
| 3 |
Qin Guo |
Novartis International Pharmaceutical |
2 |
| 3 |
David L. Rimm |
Yale University |
2 |
| #10 |
Jeffrey Thibeault |
Greenwald Industries, Incorporated |
1 |
| #10 |
Lisa Pfefferle |
Yale University |
1 |
| #10 |
Akhiro Hashimoto |
Achillion Pharmaceuticals |
1 |
| #10 |
Marie Egan |
Yale University |
1 |
| #10 |
Marcel Rozencweig |
Bristol-Myers Squibb |
1 |
| #10 |
Steve Lefkowitz |
454 Life Sciences |
1 |
| #10 |
Tony Lee |
Gilead Connecticut |
1 |
| #10 |
Michael Jeffers |
Curagen |
1 |
| #10 |
Joseph R. Bertino |
Rutgers, The State University Of New Jersey |
1 |
| #10 |
Peter W. Robinson |
Olin |
1 |
| #10 |
Stephen Wohlert |
Advanced Technologies And Regenerative Medicine |
1 |
| #10 |
Kailiang Chen |
Butterfly Network |
1 |
| #10 |
Xiangzhu Wang |
Achillion Pharmaceuticals |
1 |
| #10 |
Velizar Tchernev |
Curagen |
1 |
| #10 |
Stephen J. Yardan |
C.R. Bard |
1 |
| #10 |
Håkan Hellbergh |
Kapman Ab |
1 |
| #10 |
Fazier Bronson |
Canberra Industries |
1 |
| #10 |
Joel L. Rosenbaum |
University Of Massachusetts |
1 |
| #10 |
Xu Lin |
Vion Pharmaceuticals |
1 |
| #10 |
Robert Dally |
Eli Lilly |
1 |
| #10 |
Dimitry S.A. Nuyten |
Siemens Medical Solutions Usa |
1 |
| #10 |
Robert C. Hayden, Sr. |
Sandvik Ab |
1 |
| #10 |
Bing Ma |
Brown University |
1 |
| #10 |
Peter J. Minter |
Interlock Usa |
1 |
| #10 |
Wengang Yang |
Achillion Pharmaceuticals |
1 |
| #10 |
Nikolia Khramtsov |
Amgen |
1 |
| #10 |
Akihiro Hashimoto |
Achillion Pharmaceuticals |
1 |
| #10 |
Avinash Phadke |
Achillion Pharmaceuticals |
1 |